Abstract
The perception of pain is the result of complicated physiological and psychological processes. Pain can be treated by interrupting peripheral inputs, or by modulation of pain signals in the central nervous system. One approach that has been particularly successful has involved use of drugs that increase activity in brain and spinal cord pathways that inhibit transmission of pain signals. Drugs that increase serotonin and norepinephrine (Serotonin Norepinephrine Reuptake Inhibitors - SNRIs) have been found to be effective. These drugs are known to have antidepressant activity, and are widely used to treat depression. Although there is overlap between pain and depression, the reason these drugs are effective for treatment of pain appears to result from a direct effect on pain pathways in the central nervous system. Mechanisms of action and clinical utility of SNRIs in treatment of chronic pain are reviewed.
Keywords: serotonin/norepinephrine specific reuptake inhibitors, Diabetic Peripheral Neuropathic Pain, Postherpetic Neuralgia, HIV, Fibromyalgia, Pelvic Pain
Current Drug Therapy
Title: Treatment of Chronic Pain with Drugs that Modulate Central Nervous System Serotonin and Norepinephrine
Volume: 2 Issue: 2
Author(s): Joachim F. Wernicke, Smriti Iyengar and M. Dolores Ferrer-Garcia
Affiliation:
Keywords: serotonin/norepinephrine specific reuptake inhibitors, Diabetic Peripheral Neuropathic Pain, Postherpetic Neuralgia, HIV, Fibromyalgia, Pelvic Pain
Abstract: The perception of pain is the result of complicated physiological and psychological processes. Pain can be treated by interrupting peripheral inputs, or by modulation of pain signals in the central nervous system. One approach that has been particularly successful has involved use of drugs that increase activity in brain and spinal cord pathways that inhibit transmission of pain signals. Drugs that increase serotonin and norepinephrine (Serotonin Norepinephrine Reuptake Inhibitors - SNRIs) have been found to be effective. These drugs are known to have antidepressant activity, and are widely used to treat depression. Although there is overlap between pain and depression, the reason these drugs are effective for treatment of pain appears to result from a direct effect on pain pathways in the central nervous system. Mechanisms of action and clinical utility of SNRIs in treatment of chronic pain are reviewed.
Export Options
About this article
Cite this article as:
Wernicke F. Joachim, Iyengar Smriti and Dolores Ferrer-Garcia M., Treatment of Chronic Pain with Drugs that Modulate Central Nervous System Serotonin and Norepinephrine, Current Drug Therapy 2007; 2 (2) . https://dx.doi.org/10.2174/157488507780619086
DOI https://dx.doi.org/10.2174/157488507780619086 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Does Hypoxic Response Mediate Primary Resistance to Sunitinib in Untreated Locally Advanced Breast Cancer?
Current Cancer Drug Targets Pharmacological Approach of No-Reflow Phenomenon Related with Percutaneous Coronary Interventions
Cardiovascular & Hematological Agents in Medicinal Chemistry Flaxseed and Endotoxic Shock
Current Pharmaceutical Design Biochemical and Structural Investigations of Bothropstoxin-II, a Myotoxic Asp49 Phospholipase A2 from Bothrops jararacussu Venom
Protein & Peptide Letters Snake Venom Induced Local Toxicities: Plant Secondary Metabolites as an Auxiliary Therapy
Mini-Reviews in Medicinal Chemistry Iron Chelating Strategies in Systemic Metal Overload, Neurodegeneration and Cancer
Current Medicinal Chemistry Subclinical Vitamin B12 Deficiency and Heart Rate Variability Across Life Cycle
Current Aging Science Targeting Vascular Niche by Parathyroid Hormone
Current Medicinal Chemistry Update of Targeted Therapy-Induced Hypertension: Basics for Non-Oncology Providers
Current Hypertension Reviews Brain Protection and Cognitive Function: Cocoa Flavonoids as Nutraceuticals
Current Pharmaceutical Design Left Ventricular Hypertrophy in Isolated Aortic Stenosis: Primetime for the Ventricle
Current Pharmaceutical Biotechnology Recent Insights into the Role of Prostanoids in Atherosclerotic Vascular Disease
Current Vascular Pharmacology Loop Diuretics Strategies in Acute Heart Failure: From Clinical Trials to Practical Application
Current Drug Targets New Concepts for Glaucoma Implants - Controlled Aqueous Humor Drainage, Encapsulation Prevention and Local Drug Delivery
Current Pharmaceutical Biotechnology Empagliflozin and the Diabetic Kidney: Pathophysiological Concepts and Future Challenges
Endocrine, Metabolic & Immune Disorders - Drug Targets Autoimmune Channelopathies of the Nervous System
Current Neuropharmacology Neurologic and Cardiovascular Complications in Pediatric Life Threatening Imipramine Poisoning
Current Drug Safety Advanced Therapies For End-Stage Heart Failure
Current Cardiology Reviews Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 Balance
Current Neuropharmacology Novel Targets for Cardiac Antiarrhythmic Drug Development
Current Pharmaceutical Design